Many investors may be taken by surprise as lawmakers battle over government spending. See full story.
FDA panel recommends Pfizer’s COVID-19 booster for 65 and older, but not for the general public
A group of advisors to the Food and Drug Administration on Friday reframed a proposed approval of BioNTech and Pfizer's COVID-19 booster for the general population, and it instead recommended authorization of an additional dose of the vaccine to people at least 65 years old and those at high risk for severe disease. See full story.
Savvy stock traders use these 2 insider tips to know when to buy and sell
MACD and the MACD-Histogram can give your trading portfolio a boost. See full story.
We want to retire in the Carolinas or Virginias in a walkable town neither too large nor too small — where should we go?
A local theater or museum would be nice. See full story.
If there were a ‘Big Three’ of electric vehicle makers, who would join Tesla?
Some EV companies have confirmed that no revenue will be forthcoming for the rest of this year, raising questions about who will survive and thrive in the space. See full story.
While people with federal student loans have been allowed to pause payments during the pandemic, most borrowers haven’t gotten any closer to paying their debt. See full story.